Safety pharmacology during the COVID pandemic

Michael K. Pugsley; Yevgeniya Koshman; Tessa de Korte; Simon Authier; Michael J. Curtis

doi:10.1016/j.vascn.2021.107089

Safety pharmacology during the COVID pandemic

Michael K. Pugsley^*, Yevgeniya Koshman, Tessa de Korte, Simon Authier, Michael J. Curtis

^*Corresponding author for this work

Cardiovascular Research

Research output: Contribution to journal › Editorial › peer-review

Abstract

This editorial summarizes the content of the current themed issue of J Pharmacol Toxicol Methods derived from the 2020 Annual Safety Pharmacology Society (SPS) meeting that was held virtually September 14–17, 2020 due to the ongoing COVID-19 global pandemic. A selection of articles arising from the virtual meeting is summarized. Like previous years they continue to reflect current areas of innovation in SP including new methodologies to predict human safety, best practices for IKr current measurement, and best practice considerations for the conduct of in vivo nonclinical QT studies. The meeting included scientific content from 94 abstracts (reproduced in the current volume of J Pharmacol Toxicol Methods). This continued innovation reflects a rubric in SP that identifies problems, seeks solutions and, importantly, validates the solutions.

Original language	English
Article number	107089
Journal	Journal of pharmacological and toxicological methods
Volume	111
DOIs	https://doi.org/10.1016/j.vascn.2021.107089
Publication status	Published - 1 Sept 2021

Access to Document

10.1016/j.vascn.2021.107089

Cite this

@article{36805da0dd814f609e97b4d3563e6ac7,

title = "Safety pharmacology during the COVID pandemic",

abstract = "This editorial summarizes the content of the current themed issue of J Pharmacol Toxicol Methods derived from the 2020 Annual Safety Pharmacology Society (SPS) meeting that was held virtually September 14–17, 2020 due to the ongoing COVID-19 global pandemic. A selection of articles arising from the virtual meeting is summarized. Like previous years they continue to reflect current areas of innovation in SP including new methodologies to predict human safety, best practices for IKr current measurement, and best practice considerations for the conduct of in vivo nonclinical QT studies. The meeting included scientific content from 94 abstracts (reproduced in the current volume of J Pharmacol Toxicol Methods). This continued innovation reflects a rubric in SP that identifies problems, seeks solutions and, importantly, validates the solutions.",

author = "Pugsley, {Michael K.} and Yevgeniya Koshman and {de Korte}, Tessa and Simon Authier and Curtis, {Michael J.}",

year = "2021",

month = sep,

day = "1",

doi = "10.1016/j.vascn.2021.107089",

language = "English",

volume = "111",

journal = "Journal of pharmacological and toxicological methods",

issn = "1056-8719",

publisher = "Elsevier",

}

TY - JOUR

T1 - Safety pharmacology during the COVID pandemic

AU - Pugsley, Michael K.

AU - Koshman, Yevgeniya

AU - de Korte, Tessa

AU - Authier, Simon

AU - Curtis, Michael J.

PY - 2021/9/1

Y1 - 2021/9/1

N2 - This editorial summarizes the content of the current themed issue of J Pharmacol Toxicol Methods derived from the 2020 Annual Safety Pharmacology Society (SPS) meeting that was held virtually September 14–17, 2020 due to the ongoing COVID-19 global pandemic. A selection of articles arising from the virtual meeting is summarized. Like previous years they continue to reflect current areas of innovation in SP including new methodologies to predict human safety, best practices for IKr current measurement, and best practice considerations for the conduct of in vivo nonclinical QT studies. The meeting included scientific content from 94 abstracts (reproduced in the current volume of J Pharmacol Toxicol Methods). This continued innovation reflects a rubric in SP that identifies problems, seeks solutions and, importantly, validates the solutions.

AB - This editorial summarizes the content of the current themed issue of J Pharmacol Toxicol Methods derived from the 2020 Annual Safety Pharmacology Society (SPS) meeting that was held virtually September 14–17, 2020 due to the ongoing COVID-19 global pandemic. A selection of articles arising from the virtual meeting is summarized. Like previous years they continue to reflect current areas of innovation in SP including new methodologies to predict human safety, best practices for IKr current measurement, and best practice considerations for the conduct of in vivo nonclinical QT studies. The meeting included scientific content from 94 abstracts (reproduced in the current volume of J Pharmacol Toxicol Methods). This continued innovation reflects a rubric in SP that identifies problems, seeks solutions and, importantly, validates the solutions.

UR - http://www.scopus.com/inward/record.url?scp=85109462879&partnerID=8YFLogxK

U2 - 10.1016/j.vascn.2021.107089

DO - 10.1016/j.vascn.2021.107089

M3 - Editorial

AN - SCOPUS:85109462879

SN - 1056-8719

VL - 111

JO - Journal of pharmacological and toxicological methods

JF - Journal of pharmacological and toxicological methods

M1 - 107089

ER -

Safety pharmacology during the COVID pandemic

Abstract

Access to Document

Other files and links

Fingerprint

Cite this